1 / 18

CAMP Member Companies March 2002

CAMP. Quality by Design: A Challenge to the Pharma Industry. CAMP Member Companies March 2002. Ageing population urgent need for new medicines & greater use of pharmaceuticals. BUT. Increasing healthcare pressure to reduce use costs (and price) of pharmaceuticals.

Olivia
Télécharger la présentation

CAMP Member Companies March 2002

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CAMP Quality by Design: A Challenge to the Pharma Industry CAMP Member Companies March 2002

  2. Ageing population urgent need for new medicines & greater use of pharmaceuticals BUT Increasing healthcare pressure to reduce use costs (and price) of pharmaceuticals More informed payers greater need to demonstrate & consumers health and economic value The Changing Healthcare Scene &Impact on the Pharmaceutical Industry

  3. Pressure comes in many forms… • External pressures • diseases • shareholders • special interest groups • governmental agencies • Internal pressures • pipeline • speed to market • cost of goods • consolidation & merger savings • continuity of supply

  4. These pressures have driven innovation …

  5. Cell & Molecular Sciences R Robotics Genetics Combinatorial Chemistry Computer & Inform. Technology Informatics & Databases Supercompression of Drug Discovery Biotechnology

  6. R&D The typical pharmaceutical business model Marketing Manufacturing

  7. V Blenders

  8. Slant Cone Blenders

  9. Granulators

  10. Are manufacturing costs significant? Cost Distribution: Big Pharma (16 Companies) • Total sales > $ 300 Bn • Total costs ~ $ 250 Bn • COS > $ 90 Bn

  11. Where are the Quality and Financial Opportunities? Manufacturing Costs: Big Pharma • $45 Bn in materials • $22.5 Bn in personnel costs • $22.5 Bn in dep and operating 10% 15% 50% 25%

  12. The result of today’s manufacturing processes: • Large inefficient batch equipment • Low utilization 30 - 40 % on average • Capital and labor intensive • High inventories and excessive warehouse space • Elaborate HVAC and mechanical segregation • High transportation costs • High operating costs • Low product yields • Excessive amounts of product non-conformances • Long lead-times due to stage and final product testing

  13. Main points from this: • High tech in R & D • Relatively low tech in Manufacturing • It matters • Big Pharma manufacturing costs are $ 90 Bn • Significantly more than R&D

  14. How can we make a difference? • Technology exists • Near infra-red • Laser induced fluorescence • Continuous processing • On line monitoring and control to improve quality • Minimize troubleshooting and investigation systems • Prevent rather than repair • Financial drivers are strong • 1% yield improvement = $400 million in savings • There are significant barriers • Cultural • Organizational • Historical

  15. Opportunities • Closer links between R&D and Mfg. • Develop and design manufacturing scale processes … before registration • On line measurement and control • Continuous processing • Product plants … not component plants • Small dedicated facilities

  16. R&D The future vision pharmaceutical business model Marketing Manufacturing

  17. Commercial MOLECULE Devices LABORATORY SCALE PROCESS PROCESS DESIGN & ENGINEERING MANUFACTURING SCALE PROCESS Engineering and Operational Excellence PILOT PLANT & CT MATERIAL EQUIPMENT SELECTION AND LAYOUT DESIGN GLOBAL SOPs and VALIDATION PROTOCOLS Process for new products Project Management Registration process Roll out to sites with turnkey package

  18. Today: A challenge • Need a paradigm shift • Barriers are challenging • Environment is ready to improve quality, shorten time to market and reduce costs • Will we take the step???

More Related